Arizona Clinical Research Center, Inc.

Tucson, Arizona 85715

1 studies enrolling now · 14 studies all time

What they study most

Bladder Cancer, Breast Cancer, Cancer, Carcinoma, Small Cell, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Colo-rectal Cancer, Colorectal Cancer, Dyslipidemia, Emphysema, Esophageal Cancer, Kidney Cancer

Studies at this site

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) — Running, not enrolling
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. — Completed
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors — Completed
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01 — Completed
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma — Completed
Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC — Stopped early
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD — Completed
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD — Completed
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer — Completed
Obese Patients With Untreated Dyslipidemias — Completed